Emmanuel Bouillaud
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
Papers in
-
- Neuroendocrine Tumor Research Advances 6
-
- Retinal Diseases and Treatments 5
- Retinal and Optic Conditions 2
- Co-authors
- Ke Hu (7 shared papers)Yanfeng Wang (5 shared papers)Karina Hermosillo Reséndiz (2 shared papers)Justus G. Garweg (3 shared papers)David M. Brown (4 shared papers)Ying Wang (2 shared papers)Eric H. Souied (3 shared papers)Lixin Wang (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Clinical Therapeutics (2 papers)Blood (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Ophthalmology Retina (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Emmanuel Bouillaud
19 papers receiving 355 citations
Peers
Comparison fields: 5 of 48
- Ophthalmology 117
- Endocrinology, Diabetes and Metabolism 93
- Radiology, Nuclear Medicine and Imaging 61
- Anatomy 4
- Epidemiology 84
Countries citing papers authored by Emmanuel Bouillaud
This map shows the geographic impact of Emmanuel Bouillaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Bouillaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Bouillaud more than expected).
Fields of papers citing papers by Emmanuel Bouillaud
This network shows the impact of papers produced by Emmanuel Bouillaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Bouillaud. The network helps show where Emmanuel Bouillaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Emmanuel Bouillaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema. | 2022 | 100 |
| 2 | 2013 | 34 | |
| 3 | 2011 | 31 | |
| 4 | 2023 | 26 | |
| 5 | 2012 | 25 | |
| 6 | 2014 | 24 | |
| 7 | 2012 | 23 | |
| 8 | 2013 | 18 | |
| 9 | 2012 | 15 | |
| 10 | 2012 | 14 | |
| 11 | 2013 | 13 | |
| 12 | 2015 | 9 | |
| 13 | 2012 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2021 | 4 | |
| 16 | Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies | 2021 | 4 |
| 17 | 2025 | 3 | |
| 18 | 2012 | 2 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Emmanuel Bouillaud
Emmanuel Bouillaud is a scholar working on Epidemiology, Ophthalmology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 359 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Retinal Diseases and Treatments (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Retinal Imaging and Analysis (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Retinal and Optic Conditions (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Ophthalmology (117 citations), Endocrinology, Diabetes and Metabolism (93 citations), Radiology, Nuclear Medicine and Imaging (61 citations), Anatomy (4 citations) and Epidemiology (84 citations). Emmanuel Bouillaud has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Ke Hu, Yanfeng Wang, Karina Hermosillo Reséndiz, Justus G. Garweg, David M. Brown, Ying Wang, Eric H. Souied, Lixin Wang, Sebastián Wolf and Dilsher S. Dhoot. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Therapeutics, Blood, Cancer Chemotherapy and Pharmacology and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.